These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23993213)

  • 1. Comparison of 3 Etest(®) methods and time-kill assay for determination of antimicrobial synergy against carbapenemase-producing Klebsiella species.
    Pankey GA; Ashcraft DS; Dornelles A
    Diagn Microbiol Infect Dis; 2013 Nov; 77(3):220-6. PubMed ID: 23993213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of synergy using the combination of polymyxin B with either meropenem or rifampin against carbapenemase-producing Klebsiella pneumoniae.
    Pankey GA; Ashcraft DS
    Diagn Microbiol Infect Dis; 2011 Aug; 70(4):561-4. PubMed ID: 21767715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of in vitro methods for testing tigecycline combinations against carbapenemase-producing Klebsiella pneumoniae isolates.
    Papoutsaki V; Galani I; Papadimitriou E; Karantani I; Karaiskos I; Giamarellou H
    J Glob Antimicrob Resist; 2020 Mar; 20():98-104. PubMed ID: 31398495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of different methods for susceptibility testing of gentamicin with KPC carbapenemase-producing Klebsiella pneumoniae.
    Arena F; Giani T; Vaggelli G; Terenzi G; Pecile P; Rossolini GM
    Diagn Microbiol Infect Dis; 2015 Feb; 81(2):132-4. PubMed ID: 25533616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of antimicrobial combinations for Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.
    Hirsch EB; Guo B; Chang KT; Cao H; Ledesma KR; Singh M; Tam VH
    J Infect Dis; 2013 Mar; 207(5):786-93. PubMed ID: 23242537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of polymyxin susceptibility profile among KPC-producing Klebsiella pneumoniae using Etest and MicroScan WalkAway automated system.
    Perez LR
    APMIS; 2015 Nov; 123(11):951-4. PubMed ID: 26361367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro evaluation of antibiotic synergy for polymyxin B-resistant carbapenemase-producing Klebsiella pneumoniae.
    Elemam A; Rahimian J; Doymaz M
    J Clin Microbiol; 2010 Oct; 48(10):3558-62. PubMed ID: 20686085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates.
    Gaibani P; Lombardo D; Lewis RE; Mercuri M; Bonora S; Landini MP; Ambretti S
    J Antimicrob Chemother; 2014 Jul; 69(7):1856-65. PubMed ID: 24648503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A one-year survey of carbapenemase-producing Klebsiella pneumoniae in Italy: beyond the ICU.
    Corcione S; Rocchetti A; Argentero PA; Raso R; Zotti CM; De Rosa FG; Ghisetti V
    Clin Microbiol Infect; 2015 Feb; 21(2):e11-3. PubMed ID: 25682279
    [No Abstract]   [Full Text] [Related]  

  • 10. Antimicrobial activity evaluation and comparison of methods of susceptibility for Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacter spp. isolates.
    Rechenchoski DZ; Dambrozio AML; Vivan ACP; Schuroff PA; Burgos TDN; Pelisson M; Perugini MRE; Vespero EC
    Braz J Microbiol; 2017; 48(3):509-514. PubMed ID: 28552659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of meropenem MICs and susceptibilities for carbapenemase-producing Klebsiella pneumoniae isolates by various testing methods.
    Bulik CC; Fauntleroy KA; Jenkins SG; Abuali M; LaBombardi VJ; Nicolau DP; Kuti JL
    J Clin Microbiol; 2010 Jul; 48(7):2402-6. PubMed ID: 20484603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of disk diffusion, Etest and VITEK2 for detection of carbapenemase-producing Klebsiella pneumoniae with the EUCAST and CLSI breakpoint systems.
    Vading M; Samuelsen Ø; Haldorsen B; Sundsfjord AS; Giske CG
    Clin Microbiol Infect; 2011 May; 17(5):668-74. PubMed ID: 20649801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of carbapenemase-producing strains of Klebsiella pneumoniae and Escherichia coli to the direct antibacterial activity of NAB739 and to the synergistic activity of NAB7061 with rifampicin and clarithromycin.
    Vaara M; Siikanen O; Apajalahti J; Frimodt-Møller N; Vaara T
    J Antimicrob Chemother; 2010 May; 65(5):942-5. PubMed ID: 20167589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents.
    Bratu S; Tolaney P; Karumudi U; Quale J; Mooty M; Nichani S; Landman D
    J Antimicrob Chemother; 2005 Jul; 56(1):128-32. PubMed ID: 15917285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changes.
    Sharma R; Patel S; Abboud C; Diep J; Ly NS; Pogue JM; Kaye KS; Li J; Rao GG
    Int J Antimicrob Agents; 2017 Feb; 49(2):224-232. PubMed ID: 28040408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.
    Pournaras S; Vrioni G; Neou E; Dendrinos J; Dimitroulia E; Poulou A; Tsakris A
    Int J Antimicrob Agents; 2011 Mar; 37(3):244-7. PubMed ID: 21236643
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Huang D; Yu B; Diep JK; Sharma R; Dudley M; Monteiro J; Kaye KS; Pogue JM; Abboud CS; Rao GG
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28438930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Cha R
    Pharmacotherapy; 2008 Mar; 28(3):295-300. PubMed ID: 18294108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrepancies in fosfomycin susceptibility testing of KPC-producing Klebsiella pneumoniae with various commercial methods.
    Camarlinghi G; Parisio EM; Antonelli A; Nardone M; Coppi M; Giani T; Mattei R; Rossolini GM
    Diagn Microbiol Infect Dis; 2019 Jan; 93(1):74-76. PubMed ID: 30126624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of Klebsiella pneumoniae producing NDM-1 carbapenemase in Saint Petersburg, Russia.
    Barantsevich EP; Churkina IV; Barantsevich NE; Pelkonen J; Schlyakhto EV; Woodford N
    J Antimicrob Chemother; 2013 May; 68(5):1204-6. PubMed ID: 23315490
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.